Huifang You
- E-post:
- huifang.you@farmbio.uu.se
- Besöksadress:
- BMC, Husargatan 3
75124 Uppsala - Postadress:
- Box 591
75124 Uppsala
Publikationer
Senaste publikationer
-
Ingår i Clinical and Translational Science, 2026
- DOI för Applying a Pharmacometrics‐Enabled Machine Learning Analysis to Predict 2‐Month Culture Conversion Using Phase 2a Data in a Tuberculosis Clinical Trial
- Ladda ner fulltext (pdf) av Applying a Pharmacometrics‐Enabled Machine Learning Analysis to Predict 2‐Month Culture Conversion Using Phase 2a Data in a Tuberculosis Clinical Trial
-
Ingår i Clinical Infectious Diseases, 2025
- DOI för A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis
- Ladda ner fulltext (pdf) av A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis
-
Ingår i Pharmaceutics, 2022
- DOI för Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
- Ladda ner fulltext (pdf) av Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
Alla publikationer
Artiklar i tidskrift
-
Ingår i Clinical and Translational Science, 2026
- DOI för Applying a Pharmacometrics‐Enabled Machine Learning Analysis to Predict 2‐Month Culture Conversion Using Phase 2a Data in a Tuberculosis Clinical Trial
- Ladda ner fulltext (pdf) av Applying a Pharmacometrics‐Enabled Machine Learning Analysis to Predict 2‐Month Culture Conversion Using Phase 2a Data in a Tuberculosis Clinical Trial
-
Ingår i Clinical Infectious Diseases, 2025
- DOI för A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis
- Ladda ner fulltext (pdf) av A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis
-
Ingår i Pharmaceutics, 2022
- DOI för Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
- Ladda ner fulltext (pdf) av Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin